Cita APA

Tabák, Á. G., Anderson, J., Aschner, P., Liu, M., Saremi, A., Stella, P., . . . Meier, J. J. (2019). Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score Matched Analysis.

Citación estilo Chicago

Tabák, Ádám G., John Anderson, Pablo Aschner, Minzhi Liu, Aramesh Saremi, Peter Stella, Francisco J. Tinahones, Carol Wysham, y Juris J. Meier. Efficacy and Safety of IGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared With Basal-Bolus Regimen in Patients With Type 2 Diabetes: Propensity Score Matched Analysis. 2019.

Cita MLA

Tabák, Ádám G., et al. Efficacy and Safety of IGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared With Basal-Bolus Regimen in Patients With Type 2 Diabetes: Propensity Score Matched Analysis. 2019.